ERBIN and breast carcinoma: By the time we observe lumen filling lesions, or in HER2-overexpressing breast cancer cells, basolateral polarization is lost and HER2, Ezrin, NHERF1, HSP90, and Erbin all join together to form stable signaling complexes that localize within protruding membrane domains.